C84.7A Faturalandırılabilir, belirli kod Anaplastic large cell lymphoma, ALK-negative, breast

ICD-10-CM C84.7A identifies “Anaplastic large cell lymphoma, ALK-negative, breast” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Bölüm 2: Neoplasms

Kod talimatları

Inclusion terms1

Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)

Use additional code3
  • code to identify:
  • breast implant status (Z98.82)
  • personal history of breast implant removal (Z98.86)

Üst düzey talimatlar

Bölümler 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C84 · Mature T/NK-cell lymphomas

Excludes 11

personal history of non-Hodgkin lymphoma (Z85.72)

C84.7 · Anaplastic large cell lymphoma, ALK-negative

Excludes 11

primary cutaneous CD30-positive T-cell proliferations (C86.6-)

Resmî dizin referansları

Resmî dizin referansları (1)

Lymphoma(of) (malignant) (1)

Resmî dönüşüm geçmişi

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Geçerlilik tarihleri 2021-10-01

Önceki atama: C84.79

Geçmiş

Kod geçmişi

Son kaydedilen değişiklik · FY2022

DeğiştiDeğişmedi
FY2022

Yürürlük tarihi

  • Eklendi

Anaplastic large cell lymphoma, ALK-negative, breast

Faturalanabilir tanı kodu

CDC/NCHS · FY2022

Tüm sürümler (11)

Tüm sürümlerYürürlük tarihiKod geçmişi
FY20222021-10-01Eklendi
FY2022 · 04-012022-04-01Tabloda değişiklik yok
FY20232022-10-01Tabloda değişiklik yok
FY2023 · 04-012023-04-01Tabloda değişiklik yok
FY20242023-10-01Tabloda değişiklik yok
FY2024 · 04-012024-04-01Tabloda değişiklik yok
FY20252024-10-01Tabloda değişiklik yok
FY2025 · 04-012025-04-01Tabloda değişiklik yok
FY20262025-10-01Tabloda değişiklik yok
FY2026 · April2026-04-01Tabloda değişiklik yok
FY20272026-10-01Tabloda değişiklik yok

Bu girdi, seçilen sürümde tam bir koddur. Referans kontrolü klinik uygunluğu belirlemez veya geri ödemeyi garanti etmez.